Association of delayed commencement of adjuvant chemotherapy (AC) with inferior survival in colon cancer patients with stage II and III diseases: A national population-based cohort study

被引：0
|
作者：
Kim, Ik Yong
Kim, Young Wan
机构：
[1] Yonsei Univ, Wonju Coll Med, Wonju, South Korea
[2] Wonju Coll Med, Yonsei Univ, Div Colorectal Surg, Dept Surg, Wonju, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2017年 / 35卷 / 04期
关键词：
D O I：
10.1200/JCO.2017.35.4_suppl.669
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
669
引用
收藏
页数：1
相关论文
共 50 条
  • [1] The impact of delayed commencement of adjuvant chemotherapy (eight or more weeks) on survival in stage II and III colon cancer: a national population-based cohort study
    Kim, Young Wan
    Choi, Eun Hee
    Kim, Bo Ra
    Ko, Woo-Ah
    Do, Yeong-Mee
    Kim, Ik Yong
    ONCOTARGET, 2017, 8 (45) : 80061 - 80072
  • [2] Patterns of Adjuvant Chemotherapy Use in a Population-Based Cohort of Patients With Resected Stage II or III Colon Cancer
    Abrams, Thomas A.
    Brightly, Rick
    Mao, Jianbin
    Kirkner, Gregory
    Meyerhardt, Jeffrey A.
    Schrag, Deborah
    Fuchs, Charles S.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (24) : 3255 - 3262
  • [3] Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study
    Gao, Peng
    Huang, Xuan-zhang
    Song, Yong-xi
    Sun, Jing-xu
    Chen, Xiao-wan
    Sun, Yu
    Jiang, Yu-meng
    Wang, Zhen-ning
    BMC CANCER, 2018, 18
  • [4] Impact of timing of adjuvant chemotherapy on survival in stage III colon cancer: a population-based study
    Peng Gao
    Xuan-zhang Huang
    Yong-xi Song
    Jing-xu Sun
    Xiao-wan Chen
    Yu Sun
    Yu-meng Jiang
    Zhen-ning Wang
    BMC Cancer, 18
  • [5] Patterns of Referral for Adjuvant Chemotherapy for Stage II and III Colon Cancer: A Population-Based Study
    Chandhoke, Gursimran
    Wei, Xuejiao
    Nanji, Sulaiman
    Biagi, James
    Peng, Yingwei
    Krzyzanowska, Monika
    Mackillop, William J.
    Booth, Christopher M.
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (08) : 2529 - 2538
  • [6] Patterns of Referral for Adjuvant Chemotherapy for Stage II and III Colon Cancer: A Population-Based Study
    Gursimran Chandhoke
    Xuejiao Wei
    Sulaiman Nanji
    James Biagi
    Yingwei Peng
    Monika Krzyzanowska
    William J. Mackillop
    Christopher M. Booth
    Annals of Surgical Oncology, 2016, 23 : 2529 - 2538
  • [7] Administration of adjuvant chemotherapy for stage II-III colon cancer patients: An European population-based study
    Babaei, Masoud
    Balavarca, Yesilda
    Jansen, Lina
    Lemmens, Valery
    van Erning, Felice N.
    van Eycken, Liesbet
    Vaes, Evelien
    Sjovall, Annika
    Glimelius, Bengt
    Ulrich, Cornelia M.
    Schrotz-King, Petra
    Brenner, Hermann
    INTERNATIONAL JOURNAL OF CANCER, 2018, 142 (07) : 1480 - 1489
  • [8] A population-based study of adjuvant chemotherapy for stage-II and -III colon cancers
    Phelip, J. M.
    Molinie, F.
    Delafosse, P.
    Launoy, G.
    Tretarre, B.
    Bara, S.
    Buemi, A.
    Velten, M.
    Danzon, A.
    Ganry, O.
    Bouvier, A. M.
    Grosclaude, P.
    Faivre, J.
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2010, 34 (02): : 144 - 149
  • [9] Survival outcomes associated with completion of adjuvant oxaliplatin-based chemotherapy for stage III colon cancer: A national population-based study
    Boyle, Jemma M.
    Kuryba, Angela
    Cowling, Thomas E.
    van der Meulen, Jan
    Fearnhead, Nicola S.
    Walker, Kate
    Braun, Michael S.
    Aggarwal, Ajay
    INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (02) : 335 - 346
  • [10] Microsatellite instability and survival after adjuvant chemotherapy among stage II and III colon cancer patients: results from a population-based study
    Alwers, Elizabeth
    Jansen, Lina
    Blaeker, Hendrik
    Kloor, Matthias
    Tagscherer, Katrin E.
    Roth, Wilfried
    Boakye, Daniel
    Herpel, Esther
    Gruellich, Carsten
    Chang-Claude, Jenny
    Brenner, Hermann
    Hoffmeister, Michael
    MOLECULAR ONCOLOGY, 2020, 14 (02) : 363 - 372
12345